Lutroo Imaging is a biotechnology startup founded in 2021 with a mission to revolutionize pain diagnosis and treatment. Their patented PET radiotracer enables visualization of pain for the first time, aiming to make diagnosis faster, cheaper, and more accurate. This breakthrough technology has caught the attention of investors, with their last investment being a Seed Round led by Vye Ventures on 30 November 2022.
With their headquarters in the United States, Lutroo Imaging is paving the way for advancements in pain management. Their dedication to aiding chronic pain sufferers and commitment to innovation makes them a promising prospect for future partnerships and investment opportunities. For those interested in getting involved, Lutroo Imaging can be reached at [email protected].